Quarterly report pursuant to Section 13 or 15(d)

Unearned Revenue

v3.5.0.2
Unearned Revenue
9 Months Ended
May 31, 2016
Unearned Revenue [Text Block]
8.

Unearned Revenue

   
 

On May 14, 2016, the Company entered into a licensing agreement (the “Licensing Agreement”) with an arm’s length party (the “Licensee”) allowing the Licensee, for a two-year period, to utilize the Company’s Technology to create, test, manufacture, and sell marijuana-infused consumable and/or topical products, in the state of Colorado, with an option of extending the terms of the Licensing Agreement to Washington, Oregon, and California (the “Territorial License”). In addition to the granting of the license, the Company is required to provide support services to the Licensee in connection with the use of the Company’s Technology during the term of the Licensing Agreement.

   
 

The Company determined that the provision of the support services is a separate deliverable under the Licensing Agreement. As the support services will not be sold on a stand-alone basis, the Company is unable to establish a vendor-specific objective evidence of fair value of such services to be able to objectively allocate the Territory License fee receipts between the license and the support services. Accordingly, the Company will recognize revenue ratably over the term of the Licensing Agreement. During the nine months ended May 31, 2016, the Company received $10,000 as first installment of the Territory License Fee of which $1,181 was recognized as revenue with the remaining $8,819 deferred for recognition in future periods.